Mimetas

The Dutch SME MIMETAS, founded in 2013 in Leiden, is today’s world market leader in the emerging field of Organ-on-a-Chip technology. MIMETAS develops microfluidic Organ-on-a-Chip models to specification in OrganoPlate, markets OrganoPlate and performs self-funded R&D on ground-breaking Organ-on-a-Chip models. We believe that phenotypic tissue- and disease modeling is at the heart of 21st-century therapy development. MIMETAS has locations in Leiden and Enschede, the Netherlands, Gaithersburg, Maryland, US, and Tokyo, Japan. MIMETAS counts the majority of the top-50 pharmaceutical companies as its customers, as well as some leading consumer goods, and chemical companies. The company is run by an experienced management team supported by a seasoned board, and currently employs over 100 professionals.